1995
DOI: 10.1038/378307a0
|View full text |Cite
|
Sign up to set email alerts
|

Phosphorylation of Raf by ceramide-activated protein kinase

Abstract: The sphingomyelin pathway, initiated by hydrolysis of sphingomyelin to ceramide and stimulation of a Ser/Thr ceramide-activated protein (CAP) kinase, mediates tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 beta action. CAP kinase is membrane-bound and proline-directed, recognizing the minimal substrate motif Thr-Leu-Pro. TNF may use the sphingomyelin pathway to signal Raf1 to activate the MAP kinase cascade. Evidence shows that cytoplasmic Raf1 binds to GTP-ras upon cellular stimulation, is recruit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
205
4

Year Published

1996
1996
2005
2005

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 318 publications
(215 citation statements)
references
References 28 publications
6
205
4
Order By: Relevance
“…It is therefore possible that unlike TNF-a, cell death induced by D-e-C 8 -Cer and the other ceramide stereoisomers to arises from toxic effects due to the sustained accumulation of unphysiologically high concentrations of ceramide within cells and the prolonged activation of ceramide targets such as the CAPK and CAPP (shown to be maximally activated by 10 mM ceramide). 40,42 The use of ceramide concentrations exceeding 10 mM (25 ± 100 mM) 10,18,45 may test the cell tolerance to unphysiologically high ceramide concentrations, but may not necessarily clarify the importance of ceramide in the cell death signaling initiated by TNF-a. The ceramide concentration generated by TNF-a is significantly less than the intracellular concentration of ceramide in cells treated with D-e-C 8 -Cer (Figure 2).…”
Section: Discussionmentioning
confidence: 99%
“…It is therefore possible that unlike TNF-a, cell death induced by D-e-C 8 -Cer and the other ceramide stereoisomers to arises from toxic effects due to the sustained accumulation of unphysiologically high concentrations of ceramide within cells and the prolonged activation of ceramide targets such as the CAPK and CAPP (shown to be maximally activated by 10 mM ceramide). 40,42 The use of ceramide concentrations exceeding 10 mM (25 ± 100 mM) 10,18,45 may test the cell tolerance to unphysiologically high ceramide concentrations, but may not necessarily clarify the importance of ceramide in the cell death signaling initiated by TNF-a. The ceramide concentration generated by TNF-a is significantly less than the intracellular concentration of ceramide in cells treated with D-e-C 8 -Cer (Figure 2).…”
Section: Discussionmentioning
confidence: 99%
“…In all cases the kinase activity of KSR was dispensable, and the mutation of essential catalytic residues did not affect KSR function. To date no bona fide substrate for KSR has been found, and reports that KSR corresponds to ceramide-activated kinase [119] and phosphorylates Raf-1 [120] are disputed [49,112] and have not been widely accepted. It could well be that KSR is genuinely devoid of catalytic activity, and we are witnessing the transition from a kinase to a dedicated scaffolding protein.…”
Section: Holding It Together : Scaffolds and Adapters Ksr And Cnk (Comentioning
confidence: 99%
“…3 In particular, ceramide activates ceramide-activated protein (CAP) kinase that in turn phosphorylates Raf-1 on Thr 269, increasing its activity towards MEK (MAP kinase or ERK kinase). 4 Moreover, C2 ceramide selectively modulates calpain I expression levels, thus decreasing tau levels in differentiated PC12 cells. 5 The final outcome of C2 ceramide treatment changes according to its concentration and the cellular context.…”
Section: Introductionmentioning
confidence: 99%